Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study.

about

Small bowel gastrointestinal stromal tumor: a retrospective study of 32 cases at a single center and review of the literature

P2860

Q57099085-8CBC9214-ED93-44BC-A27A-C5A7FC917292

P2860

Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study.

Item

http://www.wikidata.org/entity/Q47103057

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Adjuvant imatinib for patients ...... a retrospective cohort study.

@en

Adjuvant imatinib for patients ...... a retrospective cohort study.

@nl

type

Item

label

Adjuvant imatinib for patients ...... a retrospective cohort study.

@en

Adjuvant imatinib for patients ...... a retrospective cohort study.

@nl

prefLabel

Adjuvant imatinib for patients ...... a retrospective cohort study.

@en

Adjuvant imatinib for patients ...... a retrospective cohort study.

@nl

P1476

Adjuvant imatinib for patients ...... a retrospective cohort study.

@en

P2093

Lin Xia

http://www.w3.org/2001/XMLSchema#string

Rui Zhao

http://www.w3.org/2001/XMLSchema#string

Wen Zhuang

http://www.w3.org/2001/XMLSchema#string

Xiaoting Wu

http://www.w3.org/2001/XMLSchema#string

Yaping Cui

http://www.w3.org/2001/XMLSchema#string

Yi Chen

http://www.w3.org/2001/XMLSchema#string

Yong Wang

http://www.w3.org/2001/XMLSchema#string

Yong Zhou

http://www.w3.org/2001/XMLSchema#string

Yuqian Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.

Sunitinib malate for gastrointestinal stromal tumour in imatinib mesylate-resistant patients: recommendations and evidence.

Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Frequent KIT mutations in human gastrointestinal stromal tumors.

P2888

s41598-017-17266-5

P304

16834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-17266-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29203825

http://www.w3.org/2001/XMLSchema#string

P932

5715066

http://www.w3.org/2001/XMLSchema#string

Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study.

about

P2860

P2860

Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932